Scilex Holding Company (NASDAQ:SCLX)’s traded shares stood at 0.36 million during the latest session, with the company’s beta value hitting 1.21. At the last check today, the stock’s price was $0.22, to imply a decrease of -4.56% or -$0.01 in intraday trading. The SCLX share’s 52-week high remains $2.63, putting it -1095.45% down since that peak but still an impressive 4.55% since price per share fell to its 52-week low of $0.21.
Analysts have given a consensus recommendation of Buy for Scilex Holding Company (SCLX), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give SCLX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.09.
Scilex Holding Company (NASDAQ:SCLX) trade information
After registering a -4.56% downside in the latest session, Scilex Holding Company (SCLX) has traded red over the past five days. The 5-day price performance for the stock is -34.02%, and -51.64% over 30 days. With these gigs, the year-to-date price performance is -48.97%.
Scilex Holding Company (SCLX) estimates and forecasts
The rating firms project that company’s revenue will grow 21.99% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 15.31M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 17.13M.Earnings reports from the last fiscal year show that sales brought in 13.46M and 10.88M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 13.72% before jumping 57.42% in the following quarter.
SCLX Dividends
Scilex Holding Company has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
We also have SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Scilex Holding Company (SCLX) shares. Going by data provided on Dec 31, 2024, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF holds roughly 5.94 shares. This is just over 2.44% of the total shares, with a market valuation of $1.31 million. Data from the same date shows that the other fund manager holds a little less at 3.71, or 1.53% of the shares, all valued at about 0.82 million.
